Mesoblast (MESO) Cost of Revenue (2015 - 2023)

Mesoblast's Cost of Revenue history runs 9 years deep, the most recent figure standing at -$19.0 million for Q2 2023.

• In Q2 2023, Cost of Revenue fell 272.16% year-over-year to -$19.0 million; the TTM figure through Jun 2023 stood at $444.3 million (up 37.35% YoY), while the FY2025 annual figure was $5.1 million, changed N/A from the prior year.
• Cost of Revenue came in at -$19.0 million for Q2 2023 at Mesoblast, down from $123.4 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $252.3 million in Q3 2022 to a low of -$339.7 million in Q2 2021.
• A 5-year average of $31.7 million and a median of $32.8 million in 2019 frame the typical range for Cost of Revenue.
• Across the five-year window, Cost of Revenue plunged 8231.21% in 2020 and soared 2748.37% in 2021, its largest moves.
• Mesoblast's Cost of Revenue stood at $86.3 million in 2019, then sank by 92.53% to $6.4 million in 2020, then jumped by 2748.37% to $183.7 million in 2021, then plunged by 52.31% to $87.6 million in 2022, then slumped by 121.69% to -$19.0 million in 2023.
• According to Business Quant data, Cost of Revenue over the past three periods registered -$19.0 million, $123.4 million, and $87.6 million for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison